Healthcare Access & Equity

PDABs say they’re helping patients. In reality, they’re muzzling public input and playing politics with life-saving medications.

One shot a year could transform HIV care. But unless we fix access and policy, these breakthroughs won’t reach those who need them most.

Copay accumulator policies make patients pay twice. It's 2025, and insurers are still profiting while patients go broke.

Political interference in public health is fueling vaccine hesitancy, outbreaks, and policy failures—at the cost of preventable lives.

New funding rules censor research on health disparities, making systemic inequities unprovable—and easier to ignore.

Federal health agencies have removed thousands of public health datasets, creating a public health crisis by Trump Admin Executive Order.

The FTC confirms PBMs are price-gouging specialty generics, raking in billions while blocking patient access to life-saving meds.

AI-driven insurance denials are costing lives, prioritizing profits over patients. Algorithms now decide who gets care—and who’s left behind

Congress faces urgent healthcare decisions before 2025—telehealth, CHC funding, and physician payments hang in the balance during lame duck.